Jacqueline Scanlan serves as Executive at HAEMONETICS CORP, where they oversee executive responsibilities. Since joining the company, Jacqueline Scanlan has executed 60 insider transactions totaling $4.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 7, 2019 involved selling 116 shares valued at $9.7K.
Jacqueline Scanlan currently holds 68,695 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jacqueline Scanlan has been a net seller of HAE stock. They have purchased $0 and sold $4.4M worth of shares.
Jacqueline Scanlan's most recent insider trade was on Mar 7, 2019, when they sold 116 shares at $83.57 per share.
Get notified when new Form 4 filings are submitted
| $104.22 |
| Discretionary |
| Sep 10, 2018 | HAE | $78.8K | Sale | 702 | $112.19 | Discretionary |
| Sep 10, 2018 | HAE | $324.1K | Sale | 2,889 | $112.19 | Discretionary |
| Sep 10, 2018 | HAE | $120.3K | Option Exercise | 2,889 | $41.64 | Discretionary |
| Sep 10, 2018 | HAE | $145.7K | Sale | 1,299 | $112.19 | Discretionary |
| Sep 10, 2018 | HAE | $49.9K | Option Exercise | 1,299 | $38.43 | Discretionary |
| Jun 11, 2018 | HAE | $0 | Award | 1,470 | $N/A | Discretionary |
| Jun 7, 2018 | HAE | $19.8K | Sale | 214 | $92.73 | Discretionary |
| Mar 6, 2018 | HAE | $8.2K | Sale | 114 | $72.23 | Discretionary |